Ibrahim El Bayoumy
Obesity has increased in prevalence around the globe; in many nations, 50–80% of people are overweight or obese. Obese population are opting for bariatric surgeries that include Laparoscopic sleeve gastrectomy. Laparoscopic Sleeve Gastrectomy is a less invasive surgical procedure and a form of bariatric surgery that has been shown to enhance the parameters of fatty liver disease and elevate rates of weight loss and type 2 DM recovery. The effect of Sleeve Gastrectomy (SG) in Nonalcoholic fatty liver diseases (NAFLD) and Nonalcoholic steatosis hepatitis in type 2 diabetes has been evaluated by using several different terms on the search engines and data bases such as Web of Science, PubMed, Google Scholar, Cochrane, Elsevier, Sage, Scopus. A total of 11 relevant studies were selected for the study discussion and evaluation. It was reported that after follow ups of years, SG poses a positive association on fatty liver diseases and type 2 diabetes and also increases rates of weight loss in obese patients.